AIDS
- WILLIAMS PL, Yu W, Van Dyke RB, Sawyer G, et al
Longitudinal changes in cardiac structure and function among young adults with
perinatal HIV infection or HIV exposure.
AIDS. 2026 Nov 6:10.1097/QAD.0000000000004636. doi: 10.1097/QAD.0000000000004636
- YAP SH, Hisham SF, Loh JSM, Hasmukharay K, et al
Diagnostic performance of the ICOPE-aligned screening tool for intrinsic capacity
in people with HIV: considerations for implementation.
AIDS. 2026 Nov 6. doi: 10.1097/QAD.0000000000004647.
- HUANG C, Shi F, Xia H, Wang K, et al
Genome-wide associated variants of dementia among people with and without HIV in
the all of us research program.
AIDS. 2026 Nov 6. doi: 10.1097/QAD.0000000000004651.
- HATHAWAY CL, Klein S, Guha A, Umutesi G, et al
Potential impact of the United States President's Emergency Plan for AIDS Relief
funding cuts on the HIV and cervical cancer burden in Kenya.
AIDS. 2026 Nov 6. doi: 10.1097/QAD.0000000000004640.
AIDS Res Hum Retroviruses
- YAVUZ S, Aksoy A, Ucer S, Kinikli S, et al
Evaluation of Tetanus Immunity in People Living with HIV: Reassessment of the
Booster Dose Schedule.
AIDS Res Hum Retroviruses. 2026 Nov 13:8892229261507443.
- ASSEFA A, Erkihun M, Berhan A, Almaw A, et al
Determinants of Virological Suppression Among HIV Patients on Antiretroviral
Therapy at Debre Tabor Comprehensive Specialized Hospital: A Cross-Sectional
Study.
AIDS Res Hum Retroviruses. 2026 Nov 10:8892229261504555.
- HO K, Edick S, Zyhowski A, Swistok A, et al
A Randomized, Double-Blind Phase 1 Safety and Pharmacokinetic Study of
Q-Griffithsin Douche Administered Rectally to HIV-1 Seronegative Adults (the
PREVENT Study).
AIDS Res Hum Retroviruses. 2026 Nov 9:8892229261502024.
Antimicrob Agents Chemother
- COSTA ACC, Lin Y-W, Chandasana H, Collins J, et al
Population pharmacokinetic analysis of lamivudine (3TC) in HIV-exposed neonates
and pediatric participants living with HIV-1 from the IMPAACT 2019 and PETITE
studies.
Antimicrob Agents Chemother. 2026 Nov 10:e0070126. doi: 10.1128/aac.00701.
Clin Infect Dis
- DE PROST N, Bay P, Le Goff M, Preau S, et al
People With Influenza Requiring ICU Admission During the 2025-2026 Season, Marked
by the Emergence of Influenza A(H3N2) Subclade K: A French Prospective Nationwide
Cohort Study.
Clin Infect Dis. 2026 Nov 11:ciag648. doi: 10.1093.
- ZHU W, Patel RR, Huang YA, Davis NL, et al
CAB-LA PrEP Prescriptions and Abandonment in the United States, January 2022-June
2025.
Clin Infect Dis. 2026 Nov 12:ciag721. doi: 10.1093.
HIV Med
- BACHA Z, Hassan ST, Ali F, Mahrukh M, et al
HIV/AIDS burden in South Asia, 1990-2023: Temporal trends, sex differences and
attributable risk factors from the Global Burden of Disease study 2023.
HIV Med. 2026 Nov 9. doi: 10.1111/hiv.70362.
- BURNS F, Parczewski M, Martinez E
Beyond borders: Making HIV prevention and care work for people on the move.
HIV Med. 2026 Nov 10. doi: 10.1111/hiv.70360.
- TROYA J, Pousada G, de Los Santos I, Mican R, et al
Immune outcomes with dolutegravir-based dual therapy versus bictegravir-based
triple therapy: A multinomial propensity score analysis.
HIV Med. 2026 Nov 12. doi: 10.1111/hiv.70365.
- MOSCHESE D, Tediosi F, Fusetti C, Baratelli A, et al
Estimating the potential need for HIV pre-exposure prophylaxis in Italy: A
national modelling study.
HIV Med. 2026 Nov 8. doi: 10.1111/hiv.70364.
- SCONZA R, Fernandes G, Rasi V, Bailey H, et al
Pregnancy and neonatal outcomes after prenatal exposure to dolutegravir: Data
from a European cohort collaboration.
HIV Med. 2026 Nov 8. doi: 10.1111/hiv.70359.
- OGUL Z, Yakit Ak E, Tandogan O
Structural determinants of outcomes related to the prevention of vertical HIV
transmission: A cross-country ecological analysis.
HIV Med. 2026 Nov 8. doi: 10.1111/hiv.70361.
- LAGI F, Rossetti B, Fabbiani M, Nigi D, et al
Applying the CONSENSUS-LAI virological failure definition in real-world practice:
Evidence from the multicentre LAHIV cohort.
HIV Med. 2026 Nov 6. doi: 10.1111/hiv.70363.
J Acquir Immune Defic Syndr
- MOROJELE NK, Yeo YR, Shenoi S, Jeetoo M, et al
Modelling minimum resource requirements to reach Ending the HIV Epidemic (EHE)
goal in KwaZulu-Natal, South Africa.
J Acquir Immune Defic Syndr. 2026 Nov 9. doi: 10.1097/QAI.0000000000004000.
- CHAGOMERANA MB, Mubiru KR, Adams SV, Moser CB, et al
Brief Report: Prognostic Value of Kaposi Sarcoma Herpes Virus-Associated Clinical
Symptom Scores in HIV-Associated Kaposi Sarcoma.
J Acquir Immune Defic Syndr. 2026;101:1378-1383.
- HAM L, Franklin DR, Ellis RJ, Letendre S, et al
Development and Internal Validation of a Two-Year Prognostic Risk Index for
Functional Decline in Adults Aging with HIV.
J Acquir Immune Defic Syndr. 2026 Nov 13. doi: 10.1097/QAI.0000000000003990.
J Clin Invest
- LIU N, Nardo D, Bhardwaj V, Glover J, et al
HIV-resistant CD19/HIV-targeted dual CAR T cells control HIV replication and B
cell lymphoma concurrently in humanized mice.
J Clin Invest. 2026 Nov 10:e211637. doi: 10.1172/JCI211637.
J Infect Dis
- HARGROVE S, Sterling RK
Beyond Steatosis: HIV-Associated Liver Fibrosis and the Limits of Current
Screening Algorithms.
J Infect Dis. 2026 Nov 7:jiag552. doi: 10.1093.
J Virol
- SHIMIZU R, Jonathan M, Terasawa H, Saito A, et al
APOBEC3 antagonism fully explains HIV-1 Vif essentiality in THP-1 cells under
interferon and differentiation conditions.
J Virol. 2026 Nov 10:e0067126. doi: 10.1128/jvi.00671.
- KITZROW JP, Kanlong JG, Nikolaitchik OA, Chameettachal A, et al
HIV-1 excludes non-guanosine nucleotides in major transcription start sites to
ensure distinct unspliced RNA fates.
J Virol. 2026 Nov 12:e0113826. doi: 10.1128/jvi.01138.
- RUIZ-GARCIA C, Perez-Godoy MD, Rivera AJ, Martinez-Barbero R, et al
Baseline immune transcriptional states predict future HIV-1 acquisition in
individuals at risk of sexual infection.
J Virol. 2026 Nov 12:e0137926. doi: 10.1128/jvi.01379.
Lancet
- GIANELLA S, Hunt PW
The overlooked role of CMV in pneumonia in infants with HIV.
Lancet. 2026;408:2042-2043.
- VAN DER ZALM MM, Barday MA
Empirical tuberculosis treatment in infants living with HIV: missed opportunities
and ways to improve outcomes.
Lancet. 2026;408:2044-2046.
- DOMINGUEZ-RODRIGUEZ S, Tagarro A, Moraleda C, Buck WC, et al
Empirical tuberculosis treatment in infants living with HIV hospitalised with
severe pneumonia in Africa (EMPIRICAL): a multicentre, randomised, open-label,
2 x 2 factorial, controlled superiority trial.
Lancet. 2026;408:2109-2124.
PLoS Med
- AFRANE AKA, Ahun MN
Beyond the child: Integrating caregiver mental health into paediatric HIV and
tuberculosis care in Africa.
PLoS Med. 2026;23:e1005287.
PLoS One
- LIONEL GJ, Binnington B, Wong RW, Jin J, et al
A cell line model for the study of CD4-negative HIV-1 infection and latent virus
reservoirs.
PLoS One. 2026;21:e0361655.
- JARSO H, Asu R, Negawo S, Ahmed K, et al
Viral suppression among adolescents and adults living with human immunodeficiency
virus in Ethiopia during the test-and-treat era.
PLoS One. 2026;21:e0362375.
- IFEORAH IM, Chinwendu J, Eneh SC, Olakunde BO, et al
Prevalence and distribution of high-risk human papillomavirus genotypes among
women living with HIV in Nigeria.
PLoS One. 2026;21:e0360438.
- NTIYANI N, Letamo G, Keetile M, Disang M, et al
Cardiovascular disease risk prediction models for people living with HIV in
Sub-Saharan Africa: A scoping review protocol.
PLoS One. 2026;21:e0352716.
- BARQAWI HJ, Samara KA, Sheiko AR, Alhariri M, et al
HIV/AIDS knowledge and stigmatizing attitudes among adult residents of the United
Arab Emirates: A cross-sectional study.
PLoS One. 2026;21:e0362376.
- KASENDWA M, Nantale R, Kusolo R, Mayega RW, et al
Fruit and vegetable consumption among people living with HIV at a large Urban HIV
Clinic in Central Uganda: A cross-sectional study.
PLoS One. 2026;21:e0361755.
Vaccine
- HOFMEISTER MG, Yankey D, Elam-Evans LD, Trahan AW, et al
Hepatitis A vaccination coverage among adolescents aged 13-17?years, United
States, 2024.
Vaccine. 2026;96:129343.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016